{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-25-000009","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2025-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.152271+00:00","generated_at":"2026-05-27T14:21:14.087626+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Elicio posts corporate deck; no extractable clinical/financial data in filing text","bullets":["Corporate presentation posted on company website dated January 23, 2025.","Presentation title: 'Targeting the Lymph Nodes to AMPlify Immunotherapy'.","No specific pipeline, financial, or milestone data available from the provided exhibit text.","Standard forward-looking statement disclaimers and market data cautions included."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-25-000009","json":"https://secwatch.observer/filing/0001601485-25-000009.json","markdown":"https://secwatch.observer/filing/0001601485-25-000009.md","text":"https://secwatch.observer/filing/0001601485-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/0001601485-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000009/angn-20250123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T14:21:14.087626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}